Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DELCATH SYSTEMS, INC.DCTH · Entity 5387 | GEN'L COUNSEL, CCO & SECY | February 17, 2026 | February 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DELCATH SYSTEMS, INC.
Report date February 17, 2026 · Filed February 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.40 · Expires 2036-02-17 | Direct | 56,500 |
Reported balance
After 2026-02-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-17 · Grant · Acquired 56,500 · Balance 56,500 F1: The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 17, 2026 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 28,250 |
Reported balance
After 2026-02-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-17 · Grant · Acquired 28,250 · Balance 28,250 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. F3: Represents an RSU award, one-third of which shall vest on February 17, 2027 with the remaining 2/3 two-thirds of the RSUs vesting in equal annual installments over the following two years. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 17, 2026 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended).
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
F3: Represents an RSU award, one-third of which shall vest on February 17, 2027 with the remaining 2/3 two-thirds of the RSUs vesting in equal annual installments over the following two years. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2026 Filed Feb 19, 2026 02:30 UTC | DELCATH SYSTEMS, INC. DCTH · Entity 5387 | GrantRestricted Stock Units · Derivative | 28,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001929605-26-000003 · form4-02182026_090210.xml · derivative · entry 2 Hoffman David L. · CIK 0001929605 · GEN'L COUNSEL, CCO & SECY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,250 Underlying: Common Stock · 28,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Represents an RSU award, one-third of which shall vest on February 17, 2027 with the remaining 2/3 two-thirds of the RSUs vesting in equal annual installments over the following two years. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date. F3 · derivative.expiration_date: Represents an RSU award, one-third of which shall vest on February 17, 2027 with the remaining 2/3 two-thirds of the RSUs vesting in equal annual installments over the following two years. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:30 UTC | DELCATH SYSTEMS, INC. DCTH · Entity 5387 | GrantStock Option (Right to Buy) · Derivative | 56,500 | $0.00 Strike: $9.40 | $0.00 |
DisclosureSEC source: 0001929605-26-000003 · form4-02182026_090210.xml · derivative · entry 1 Hoffman David L. · CIK 0001929605 · GEN'L COUNSEL, CCO & SECY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,500 Underlying: Common Stock · 56,500 shares Expires 2036-02-17 F1 · derivative.exercise_date: The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 17, 2026 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended). Read SEC document |
| February 07, 2025 Filed Feb 8, 2025 00:32 UTC | DELCATH SYSTEMS, INC. DCTH · Entity 5387 | GrantStock Option (Right to Buy) · Derivative | 113,000 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001415889-25-003410 · form4-02082025_120230.xml · derivative · entry 1 Hoffman David L. · CIK 0001929605 · GEN'L COUNSEL, CCO & SECY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,000 Underlying: Common Stock · 113,000 shares Expires 2035-02-07 F1 · derivative.exercise_date: The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 7, 2025 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended). Read SEC document |
| March 19, 2024 Filed Mar 19, 2024 20:57 UTC | DELCATH SYSTEMS, INC. DCTH · Entity 5387 | GrantCommon Stock | 20,161 | $3.72 | $74,998.92 |
DisclosureSEC source: 0001415889-24-008576 · form4-03192024_080330.xml · nonDerivative · entry 1 Hoffman David L. · CIK 0001929605 · GEN'L COUNSEL, CCO & SECY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,330 F1 · balance_after: Includes 14,169 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:43 UTC | DELCATH SYSTEMS, INC. DCTH · Entity 5387 | GrantStock Option (Right to Buy) · Derivative | 100,500 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001415889-24-003758 · form4-02142024_090257.xml · derivative · entry 1 Hoffman David L. · CIK 0001929605 · GEN'L COUNSEL, CCO & SECY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,500 Underlying: Common Stock · 100,500 shares Expires 2034-02-12 F1 · derivative.exercise_date: The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 12, 2024 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended). Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 21:20 UTC | DELCATH SYSTEMS, INC. DCTH · Entity 5387 | PurchaseCommon Stock | 40,000 | $2.48 | $99,200.00 |
DisclosureSEC source: 0001209191-23-056051 · doc4.xml · nonDerivative · entry 1 Hoffman David L. · CIK 0001929605 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.40 to $2.49 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| June 12, 2023 Filed Jun 22, 2023 01:20 UTC | DELCATH SYSTEMS, INC. DCTH · Entity 5387 | GrantStock Option (Right to Buy) · Derivative | 59,813 | $0.00 Strike: $7.25 | $0.00 |
DisclosureSEC source: 0000899243-23-016199 · doc4.xml · derivative · entry 1 Hoffman David L. · CIK 0001929605 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,813 Underlying: Common Stock · 59,813 shares Expires 2033-06-12 F1 · derivative.exercise_date: The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on July 12, 2023 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended). Read SEC document |
| February 08, 2023 Filed Jan 26, 2024 21:24 UTC | DELCATH SYSTEMS, INC. DCTH · Entity 5387 | GrantStock Option (Right to Buy) · Derivative | 46,800 | $0.00 Strike: $4.67 | $0.00 |
DisclosureSEC source: 0001415889-24-001867 · form4-01262024_090136.xml · derivative · entry 1 Hoffman David L. · CIK 0001929605 · GEN'L COUNSEL, CCO & SECY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,800 Underlying: Common Stock · 46,800 shares Expires 2033-02-08 F1 · derivative.exercise_date: The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 8, 2023 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions ofthe Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.